Editorial
Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways
Translational Lung Cancer Research
2022;
11
(8)
:1517-1521
.
(31 August 2022)
Circulating mitochondrial DNA as a biomarker for lung cancer screening
Translational Lung Cancer Research
2022;
11
(8)
:1522-1525
.
(31 August 2022)
Original Article
Prognostic implications of cellular senescence in resected non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(8)
:1526-1539
.
(31 August 2022)
A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes
Translational Lung Cancer Research
2022;
11
(8)
:1540-1554
.
(31 August 2022)
Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
Translational Lung Cancer Research
2022;
11
(8)
:1555-1566
.
(31 August 2022)
First-in-human results of targeted intraoperative molecular imaging for visualization of ground glass opacities during robotic pulmonary resection
Translational Lung Cancer Research
2022;
11
(8)
:1567-1577
.
(31 August 2022)
Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(8)
:1578-1590
.
(31 August 2022)
Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China
Translational Lung Cancer Research
2022;
11
(8)
:1591-1605
.
(31 August 2022)
Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
Translational Lung Cancer Research
2022;
11
(8)
:1606-1618
.
(31 August 2022)
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab
Translational Lung Cancer Research
2022;
11
(8)
:1619-1630
.
(31 August 2022)
Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis
Translational Lung Cancer Research
2022;
11
(8)
:1631-1642
.
(31 August 2022)
Clinical use of 18F-FDG PET/CT in the differential diagnosis of patients with primary and secondary adenoid cystic carcinoma of the lung: a retrospective cohort study
Translational Lung Cancer Research
2022;
11
(8)
:1643-1656
.
(31 August 2022)
Efficacy and safety of anlotinib combined with carboplatin and pemetrexed as first-line induction therapy followed by anlotinib plus pemetrexed as maintenance therapy in EGFR/ALK wild-type advanced non-squamous non-small cell lung cancer in China: a multicenter, single-arm trial
Translational Lung Cancer Research
2022;
11
(8)
:1657-1666
.
(31 August 2022)
The incidence and risk factors of acute pain after preoperative needle localization of pulmonary nodules: a cross-sectional study
Translational Lung Cancer Research
2022;
11
(8)
:1667-1677
.
(31 August 2022)
Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort
Translational Lung Cancer Research
2022;
11
(8)
:1678-1691
.
(31 August 2022)
Comparison of operation time, efficacy and safety between through-the-scope stent and over-the-while stent in malignant central airway obstruction: a multi-center randomized control trial
Translational Lung Cancer Research
2022;
11
(8)
:1692-1701
.
(31 August 2022)
The improved success rate and reduced complications of a novel localization device vs. hookwire for thoracoscopic resection of small pulmonary nodules: a single-center, open-label, randomized clinical trial
Translational Lung Cancer Research
2022;
11
(8)
:1702-1712
.
(31 August 2022)
iMDT Corner
Locally advanced undifferentiated small round cell sarcoma of the lung with novel SDCCAG8-AKT3 fusion and type II tumor immunity in the microenvironment: a rare case report
Translational Lung Cancer Research
2022;
11
(8)
:1713-1721
.
(31 August 2022)
Editorial Commentary
Limited-anatomic resection for ground-glass like lung cancer—simplicity does not mean inefficacy
Translational Lung Cancer Research
2022;
11
(8)
:1722-1724
.
(31 August 2022)
Letter to the Editor
PD-L1 expression in pulmonary lymphoepithelioma-like carcinoma: is it a prognostic biomarker?
Translational Lung Cancer Research
2022;
11
(8)
:1725-1726
.
(31 August 2022)
Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer
Translational Lung Cancer Research
2022;
11
(8)
:1727-1730
.
(31 August 2022)
Erratum
Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
Translational Lung Cancer Research
2022;
11
(8)
:1731-1733
.
(31 August 2022)
